Key result
Maintaining sinus rhythm is linked to MR improvement in ~77% of patients versus recurrent AF.
Why the study?
AF causes functional MR and TR or can occur as a consequence of valvular dysfunction, but data on the success of restoring SR and subsequent MR/TR improvement remain limited.
Does rhythm control via cardioversion or ablation improve functional mitral and tricuspid regurgitation in patients with atrial fibrillation?
Observational (n=80)
No
Does rhythm control via cardioversion or ablation improve functional mitral and tricuspid regurgitation in patients with atrial fibrillation?
Restoring and maintaining sinus rhythm in patients with atrial fibrillation significantly reduces the severity of functional mitral and tricuspid regurgitation and promotes favorable cardiac reverse remodeling.
Rhythm control may reduce functional MR in AF; hypothesis-generating and requires RCTs before practice change.
Background Functional mitral and tricuspid regurgitation (MR and TR) are caused by changes in atrial and/or ventricular geometry. Atrial fibrillation (AF) has been identified as a cause of functional MR and TR, but the arrhythmia may also occur as a consequence of the valvular dysfunction. Data on the success of restoring sinus rhythm (SR) and subsequent MR/TR improvement remain limited. This study reports findings from the prospective Berlin-FMTR registry, which included patients with AF and newly diagnosed moderate or worse functional MR or TR undergoing cardioversion or ablation. Methods and results Eighty patients (46% male, median age 73.7 years) with persistent AF and at least moderate MR or TR underwent rhythm control via cardioversion or catheter ablation. Follow-up assessments were conducted at 3 and 12 months. After a mean of 11.6 ± 9 months, 45 patients (56%) remained in SR. At 12 months, 56% of patients with baseline moderate or worse MR improved to mild MR. Among those in SR, this rose to 77% versus 38% with AF recurrence. Only patients in SR showed significant improvements in LVEF, left atrial size, and heart failure symptoms. Similarly, 54% of patients with at least moderate TR at baseline improved to mild TR at 12 months. Among those maintaining SR, 70% showed TR improvement, compared to 35% with recurrent AF. Right ventricular function (TAPSE, RV diameter/volume) improved only in those in SR. Conclusion Restoring and maintaining SR led to significant reductions in MR and TR severity and cardiac remodeling. These findings support rhythm control as a key therapeutic strategy in patients with AF and functional MR/TR.
No takes yet. Share an insight, caveat, or question.
Attanasio et al. (2026) conducted an observational in Patients with persistent atrial fibrillation and newly diagnosed at least moderate functional mitral or tricuspid regurgitation undergoing cardioversion or catheter ablation (n=80). Rhythm control via cardioversion or catheter ablation vs. Recurrent atrial fibrillation was evaluated on Improvement in valvular regurgitation grade (≥1 grade reduction) from baseline to 12-month follow-up. Restoring and maintaining sinus rhythm through cardioversion or catheter ablation improved moderate or worse mitral regurgitation to mild in 77% of patients at 12 months compared to 38% improvement with recurrent atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: